Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy5 maleimide non sulfonated 5mg'

Search results for: 'cy5 maleimide non sulfonated 5mg'

Items 51-58 of 58

Page
per page
  1. Danusertib (PHA-739358)
    A4116 Danusertib (PHA-739358)
     2 Citation
    Target: Aurora Kinases
    Summary: Pan-aurora kinase inhibitor
      ≥23.75 mg/mL
  2. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,isotype-selective and potent
      insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
  3. I-BET-762
    B1498 I-BET-762
     4 Citation
    Target: Bromodomains
    Summary: BET inhibitor,highly potent
      ≥21.19 mg/mL
  4. Rocilinostat (ACY-1215)
    A4083 Rocilinostat (ACY-1215)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Selective HDAC6 inhibitor
      ≥21.675 mg/mL
  5. Bromodomain Inhibitor, (+)-JQ1
    A1910 Bromodomain Inhibitor, (+)-JQ1
     38 Citation
    Target: Bromodomains
    Summary: BET bromodomain inhibitor
      ≥22.85 mg/mL
  6. Molidustat (BAY85-3934)
    B5861 Molidustat (BAY85-3934)
    Target: HIF-PH
    Summary: Novel HIF-PH inhibitor
  7. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL
  8. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL

Items 51-58 of 58

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 5item
  2. Aurora Kinase 11item
  3. HDAC 16item
  4. Histone Acetyltransferases 1 item
  5. Histone Demethylases 3item
  6. Histone Methyltransferase 6item
  7. HIF 1 item
  8. JAK 9item
  9. PARP 4item
  10. Sirtuin 1 item
  11. Sphingosine Kinase-2 1 item
Specificity
  1. Selective 36item
Reversibility
  1. Reversible 3item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 13item
  3. Aurora Kinases 12item
  4. EZH2 1 item
  5. Bromodomains 4item
  6. FLT3 4item
  7. PLK 1 item
  8. VEGFR 1 item
  9. RET 1 item
  10. Hydrolase 1 item
  11. MEK 1 item
  12. DOT1L 1 item
  13. FGFR 2item
  14. Sir2-like Family Deacetylases (Sirtuins) 1 item
  15. Src 4item
  16. Trk Receptors 1 item
  17. STAT 1 item
  18. JAK 10item
  19. LRRK2 1 item
  20. PARP 4item
  21. ALK 1 item
  22. Hck 1 item
  23. Histone Demethylases 1 item
  24. Protein Arginine Methyltransferases 1 item
  25. c-RET 1 item
  26. VEGFR3/FLT4 1 item
  27. NTRK1/TRKA 1 item
  28. CSF-1R/c-Fms 1 item
  29. HDAC 2item
  30. KDM 1 item
  31. HIF-PH 1 item
  32. L3MBTL 1 item
  33. TYK2 1 item
  34. MUSK 1 item
  35. MAP3K 1 item
  36. Lck 1 item
  37. FGR 1 item
  38. YES 1 item
  39. Fyn 1 item
  40. ARG 1 item
  41. LSD 1 item
  42. PRMT 1 item
  43. SK 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 6item
  3. Bladder Cancer 1 item
  4. Breast Cancer 9item
  5. Cancer 33item
  6. Castration-resistant Prostate Cancer 1 item
  7. Cervical Cancer 1 item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 4item
  10. Diffuse Large B-cell Lymphoma 1 item
  11. Dyskinesia 1 item
  12. Friedreich's Ataxia 1 item
  13. Glioblastoma 1 item
  14. HIV 1 item
  15. HIV Infections 1 item
  16. Inflammatory Diseases 1 item
  17. Leukemia 2item
  18. Lung Cancer 3item
  19. Lymphoma 2item
  20. Mixed Lineage Leukemia 1 item
  21. Multiple Myeloma 3item
  22. Myelofibrosis 1 item
  23. Neuroblastoma 2item
  24. Non-small Cell Lung Cancer 1 item
  25. Ovarian Cancer 2item
  26. Pancreatic Cancer 2item
  27. Prostate Cancer 5item
  28. Psoriasis 1 item
  29. Renal Cancer 1 item
  30. Rheumatoid Arthritis 1 item
  31. Type 2 Diabetes 1 item